Gatralimab
Based on 1 publication(s) in Google Scholar
Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.
For research use only. We do not sell to patients.
- Purity : 97.94%
- CAS No.: 1826020-80-7
- Molecular Weight:145 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Gatralimab
More
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
CD52
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CD52 Protein, Human (His, HY-P72123) can bind Gatralimab. The EC50 for this effect is 13.12 ng/mL.
Chemical Information
-
CAS No. 1826020-80-7
-
Appearance Liquid
-
Molecular Weight 145 kDa
-
Color Colorless to light yellow
-
SMILES
[Gatralimab]
-
Synonyms
GZ-402668
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
NPJ Breast Cancer
CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy. [Abstract]2026 Jan 24;12(1):29. PMID: 41580422
Purity & Documentation
-
Data Sheet (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)